uniQure announced that six data presentations, of which three are oral presentations, will be delivered at the upcoming American Society of Gene and Cell Therapy 21st Annual Meeting held in Washington D.C., April 29 – May 2, 2019. “We have made significant progress over the past year in advancing our gene therapy expertise through expansion of our research pipeline,” stated Sander van Deventer, M.D., Ph.D., chief scientific officer at uniQure. “We are very pleased to have such a strong showing at ASGCT, and to have new preclinical data featured in Huntington’s disease, hemophilia A and Fabry disease. We look forward to having these data prominently featured at the conference.”
https://thefly.com/landingPageNews.php?id=2892693
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.